Course Director

Jacek Jassem, Radiation Oncologist, Akademia Medyczna, Gdansk (PL)

Teachers

David Azria, Oncologist, CRLC Val d'Aurelle, Montpellier (FR)
Robert Glynne-Jones, Clin. Oncologist, Mount Vernon Cancer Centre, Northwood (UK)
Rafal Dziadziuszko, Radiation Oncologist, Academia Medyczna, Gdansk (PL)
Vincent Grégoire, Radiation Oncologist, Cliniques Universitaires St-Luc, Brussels (BE)
Christophe Hennequin, Radiation Oncologist, Hôpital Saint-Louis, Paris (FR)
Barbara Jereczek-Fossa, Radiation Oncologist, European Institute of Oncology, Milano (IT)
Eric Lartigau, Radiation Oncologist, Centre Oscar Lambret, Lille (FR)
Roger Stupp, Medical Oncologist, Multidisciplinary Oncology Center, University Hospital (CHUV), Lausanne (CH) 

Course Rationale

Effective cancer treatment necessitates both high efficacy of local treatment and combating sub-clinical systemic disease. Consequently, cancer therapy today involves various combinations of local and systemic treatment modalities. Of those, combining drugs and radiation has been attracting particular attention both in terms of its biological rationale and its potential of increasing the therapeutic outcome. The course aims at updating participants about established and emerging knowledge in this field. It will provide the key-messages that biological and clinical research is bringing to the oncology community nowadays.

Course aim

To update participants about biological effects of combining drugs and radiation in normal and tumour tissue.
Presenting evidence-based clinical applications of combined modality treatment using drugs and radiation in major human malignancies.
Stimulating case-based discussion on the interdisciplinary treatment of cancer.
Presenting future perspectives for combining drugs and radiation

Target Group

The target group consists of radiotherapists and medical oncologists involved in the multidisciplinary treatment of cancer.

Educational programme

General lectures: 
·        Combining drugs with radiation: Quantifying the therapeutic gain
·        Combining new drugs with radiotherapy
·        Radiation and non-cytotoxic drugs 
·        Hypoxic cell radiosensitizers
·        Cytoprotective agents and radiotherapy: what is safe and what is not?
.        Rationale and results of altered fractionation  & Combination of RT with CT       
·        Designing clinical trials for combined modality treatments
.       ¨Personalizing cancer therapy: rationale and challenges

 Site specific lectures including practical case discussions:
·        Head and neck cancer
·        Lung cancer (small and non-small cell)
·        Breast cancer
·        Prostate cancer
·        Bladder cancer
·        Cervical cancer
·        Oesophageal cancer
·        Rectal cancer         
·        Anal canal
·        Pancreas
·        Gastric cancer 
·        Brain tumours
·        Lymphomas